Page results
-
UCLH’s trial of the world’s first ‘gene silencing’ drug for Alzheimer’s disease has progressed into a larger and later stage trial, after promising early results.
-
An international clinical trial testing a novel cancer immunotherapy which may prevent skin cancer from recurring has recruited its first patients at UCLH.
-
The UCLH and Great Ormond Street Hospital paediatric neuro-oncology service, which treats children with brain cancer, has been designated as one of six new ‘Tessa Jowell Centres of Excellence’.
-
How we use your information at UCLH: what you need to know
-
The Digital Innovation Hub will create a safe space for innovators across UCLH, UCL and third-party collaborators to work effectively together to solve problems that add value to patients, staff, UCLH and the wider NHS.
-
Next generation testing, artificial intelligence, advanced mass spectrometry and machine learning is about to be used for diagnostics in the U.K. thanks to a new partnership between UCLH and Guilford Street Laboratories (GSL).
-
UCLH is delighted that His Majesty King Charles III has accepted the patronages of University College Hospital and the Royal London Hospital for Integrated Medicine.
-
Information for new neuro-otology patients
-
A huge thank you and well done to everyone who ran the London Marathon last weekend to support UCLH.
-
"Patient-initiated follow-up” appointments (PIFU ) allow you to arrange a follow-up appointment if and when you need it.
